Evaluation of the Impact of Elexacaftor/Tezacaftor/Ivacaftor on aerobic capacity in children with Cystic Fibrosis aged 6 to 11 years: Actual observations and clinical perspectives Margarita Pérez-Ruiz; Mats te Bos; Patricia Fernández García; Cristina de Manuel Gómez; Ana Morales-Tirado; Alejandro López-Neyra; Marta Ruiz de Valbuena Maíz; Margarita Rubio; Verónica Sanz-Santiago;

Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases Eusebi Chiner-Vives; Rosa Cordovilla-Pérez; David de la Rosa-Carrillo; Marta García-Clemente; José Luis Izquierdo-Alonso; Remedios Otero-Candelera; Luis Pérez-de Llano; Jacobo Sellares-Torres; José Ignacio de Granda-Orive;

[Translated article] Biological Biomarkers in Respiratory Diseases Francisco García-Río; Bernardino Alcázar-Navarrete; Diego Castillo-Villegas; Catia Cilloniz; Alberto García-Ortega; Virginia Leiro-Fernández; Irene Lojo-Rodriguez; Alicia Padilla-Galo; Carlos A. Quezada-Loaiza; Jose Antonio Rodriguez-Portal; Manuel Sánchez-de-la-Torre; Oriol Sibila; Miguel A. Martínez-García;